D47.Z2
Castleman disease
Clinical Classification Guidelines
Excludes Type 2
- Kaposi's sarcoma (C46.-)
Code Also
- , if applicable, human herpesvirus 8 infection (B10.89)
Medical Intelligence & Overview
Castleman disease is a rare disorder characterized by non-cancerous growths that develop in the lymph nodes and related tissues. It can affect people of all ages but is most commonly diagnosed in adults. The disease can present in different forms, ranging from localized (affecting a single lymph node or region) to multicentric (involving multiple lymph nodes throughout the body). Understanding its symptoms, causes, and treatment options is important for patients and caregivers.
Causes & Symptoms
Clinical Causes: The exact cause of Castleman disease remains unknown, though it is believed to be related to abnormal immune system activity. Some cases have been linked to infections, particularly viruses such as human herpesvirus 8 (HHV-8) and HIV. Genetic factors may also play a role, but research is ongoing to fully understand the underlying mechanisms. In multicentric Castleman disease, immune system dysregulation contributes to widespread lymph node growth.
Key Symptoms: Swelling in the lymph nodes, commonly in the neck, armpits, or groin. Fever and night sweats. Unexplained weight loss. Fatigue and malaise. Enlargement of organs such as the spleen or liver. General discomfort or pain in affected areas. Skin rash or skin changes in some cases. In multicentric Castleman disease, symptoms can be more severe and systemic, including difficulty breathing or swelling in the chest or abdomen.
Diagnostic & Treatment
Diagnosis Path: Diagnosing Castleman disease involves a combination of clinical evaluation, imaging tests, and laboratory procedures. Typically, a biopsy of affected lymph nodes is performed to examine cellular structure and rule out other conditions like lymphoma or infections. Additional tests may include blood work to look for anemia, inflammation markers, and viral infections such as HHV-8 or HIV. Imaging modalities like CT scans or ultrasounds help assess the extent of lymph node involvement. A multidisciplinary approach is often needed for accurate diagnosis.
Treatment Protocols: Treatment options depend on the type and severity of the disease. Common approaches include: - **Surgical removal** of localized lymph node growths. - **Medications** such as corticosteroids to reduce inflammation. - **Chemotherapy or immunotherapy** for multicentric Castleman disease, especially in cases associated with viral infections or immune dysregulation. - **Targeted therapies** like tocilizumab, which blocks specific immune pathways. - **Antiviral therapy** if associated with viral infections. Close follow-up and monitoring are essential to adjust treatment plans and manage potential complications. In some cases, stem cell transplantation may be considered for severe or refractory cases.
Clinical Advice & FAQs
Billing Guidance
Is D47.Z2 a billable ICD-10 code?
Yes, D47.Z2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D47.Z2?
Clinical documentation must specify the nature of Castleman disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference